We’re working at full force to put Bayer back on a profitable growth path: Bill Anderson, CEO, Bayer
Bayer expects 2025 to be the most difficult year of its turnaround
Bayer expects 2025 to be the most difficult year of its turnaround
The implementation, spearheaded by Deloitte Consulting, brings together domain expertise and cutting-edge technology
A new weapon in the global fight against malaria
The newly inaugurated facility bridges this gap by offering metro-grade treatment closer to home
Access to NIPT, TB and Rare Disease diagnostics to benefit thousands of patients nationwide
Over 1500 stakeholders representing food businesses, packaging industries, recycling associations, regulatory bodies, environmental organizations, consumer groups, farmer groups, government departments participated in the consultation
Anushree has been with Abbott since 2021 and currently serving as Head of Strategy and Portfolio
More than 40 types of Amyloid proteins are discovered till date
Padmanabhan brings over two decades of extensive experience in FMCG sector
Subscribe To Our Newsletter & Stay Updated